Metric Finance
LearnFAQ
LearnFAQ

Learn / SPTX

NASDAQ: SPTX

Seaport Therapeutics (SPTX) stock, explained like you're 5

Seaport Therapeutics trades on the Nasdaq under the ticker SPTX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 972 million dollars.

Ticker
SPTX
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 972 million dollars

Is Seaport Therapeutics a small, medium or large cap company?

No. Seaport Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 972 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Seaport Therapeutics makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves SPTX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Seaport Therapeutics (NASDAQ:SPTX) Stock Price Up 3.6% Here's Why (MarketBeat)
  • Seaport Therapeutics (Nasdaq:SPTX) Stock Analysis (Simply Wall Street)
  • Canaccord Genuity Initiates Coverage on Seaport Therapeutics With Buy Rating, $28 Price Target (Yahoo Finance)
  • An experimental drug showed 10 times less variation in levels than the original medicine (Stock Titan)
  • $SPTX stock is up 12% today. Here's what we see in our data. (Quiver Quantitative)

Follow SPTX in your daily brief

Each trading day at 5 PM ET we post what happened to Seaport Therapeutics and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow SPTX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Seaport Therapeutics stock

What does Seaport Therapeutics do?

Seaport Therapeutics trades on the Nasdaq under the ticker SPTX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 972 million dollars.

What is the ticker symbol for Seaport Therapeutics?

Seaport Therapeutics trades under the ticker SPTX on the Nasdaq.

What is Seaport Therapeutics's market cap?

Seaport Therapeutics is a small cap stock with a market cap of about 972 million dollars.

How does Seaport Therapeutics make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves SPTX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow SPTX stock every day?

Add SPTX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow SPTX daily

A free brief on Seaport Therapeutics and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare SPTX: SPTX vs NVS, SPTX vs AZN, SPTX vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed